Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank
Urinary albumin-creatinine ratio (UACR)
Male
CKD progression
Hospitalization for heart failure (HHF)
Kidney failure
610
Chronic kidney disease (CKD)
Kidney
03 medical and health sciences
Nonalbuminuric DKD
0302 clinical medicine
616
Albuminuria
Humans
Diabetic Nephropathies
Prospective Studies
Mortality
Renal Insufficiency, Chronic
Type 2 diabetes (T2D)
Biological Specimen Banks
Heart Failure
Cardiovascular disease (CVD)
Type 2 diabetes
Prognosis
3. Good health
Phenotype
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Estimated glomerular filtration rate (eGFR)
Hong Kong
Female
Diabetic kidney disease (DKD)
Glomerular Filtration Rate
DOI:
10.1053/j.ajkd.2021.11.011
Publication Date:
2022-01-06T16:24:27Z
AUTHORS (116)
ABSTRACT
Rationale & ObjectiveNonalbuminuric diabetic kidney disease (DKD) has become the prevailing DKD phenotype. We compared risks of adverse outcomes among patients with this phenotype other phenotypes.Study DesignMulticenter prospective cohort study.Settings Participants19,025 Chinese adults type 2 diabetes enrolled in Hong Kong Diabetes Biobank.ExposuresDKD phenotypes defined by baseline estimated glomerular filtration rate (eGFR) and albuminuria: no (no decreased eGFR or albuminuria), albuminuria without eGFR, albuminuria, eGFR.OutcomesAll-cause mortality, cardiovascular (CVD) events, hospitalization for heart failure (HF), chronic (CKD) progression (incident sustained reduction ≥40%).Analytical ApproachMultivariable Cox proportional cause-specific hazards models to estimate relative death, CVD, HF, CKD progression. Multiple imputation was used missing covariates.ResultsMean participant age 61.1 years, 58.3% were male, mean duration 11.1 years. During 54,260 person-years follow-up, 438 deaths, 1,076 CVD 298 hospitalizations 1,161 episodes occurred. Compared no-DKD subgroup, subgroup had higher all-cause mortality (hazard ratio [HR], 1.59 [95% CI, 1.04-2.44]), HF (HR, 3.08 1.82-5.21]), 2.37 1.63-3.43]), but risk not significantly greater 1.14 0.88-1.48]). The setting eGFR. A sensitivity analysis that excluded participants <30 mL/min/1.73 m2 yielded similar findings.LimitationsPotential misclassification because drug use.ConclusionsNonalbuminuric associated than DKD, regardless Nonalbuminuric phenotypes. Multicenter study. 19,025 Biobank. All-cause ≥40%). Multivariable covariates. Mean findings. Potential use.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (28)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....